当前位置: 首页 > 详情页

Amygdala-Targeted Relief of Neuropathic Pain: Efficacy of Repetitive Transcranial Magnetic Stimulation in NLRP3 Pathway Suppression

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Hunan Univ Med, Peoples Hosp Huaihua 1, Gen Hosp, Dept Anesthesiol, 144 South Jinxi Rd, Huaihua 418000, Hunan, Peoples R China [2]Univ South China, Affiliated Hosp 1, Dept Anesthesiol, Hengyang 421001, Peoples R China [3]Univ Sci & Technol China, Affiliated Hosp USTC 1, Dept Anesthesiol, Div Life Sci & Med, Hefei 230036, Anhui, Peoples R China [4]Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21287 USA [5]Capital Med Univ, Xuanwu Hosp, Dept Pain Management, 45 Changchun St, Beijing 100053, Peoples R China [6]Cedars Sinai Med Ctr, Board Governors Regenerat Med Inst, Los Angeles, CA 90048 USA
出处:
ISSN:

关键词: Neuropathic pain Repetitive Transcranial Magnetic Stimulation Amygdala Integrin alpha v beta 3 P2 x 7R NLRP3 Inflammatory Pathway

摘要:
This study investigates the effectiveness of repetitive transcranial magnetic stimulation (rTMS) as a nonpharmacological approach to treating neuropathic pain (NP), a major challenge in clinical research. Conducted on male Sprague-Dawley rats with NP induced through chronic constriction injury of the sciatic nerve, the research assessed pain behaviors and the impact of rTMS on molecular interactions within the amygdala. Through a comprehensive analysis involving Mechanical Withdrawal Threshold (MWT), Thermal Withdrawal Latency (TWL), RNA transcriptome sequencing, RT-qPCR, Western blotting, immunofluorescence staining, and Co-Immunoprecipitation (Co-IP), the study focused on the expression and interaction of integrin alpha v beta 3 and its receptor P2X7R. Findings reveal that rTMS significantly influences the expression of integrin alpha v beta 3 in NP models, suggesting an inhibition of the NP-associated NLRP3 inflammatory pathway through the disruption of integrin alpha v beta 3-P2X7R interactions. These outcomes highlight the potential of rTMS in alleviating NP by targeting molecular interactions within the amygdala, offering a promising therapeutic avenue for managing NP.

基金:
语种:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2023]版:
大类 | 2 区 医学
小类 | 2 区 神经科学
最新[2023]版:
大类 | 2 区 医学
小类 | 2 区 神经科学
JCR分区:
出版当年[2022]版:
Q2 NEUROSCIENCES
最新[2023]版:
Q1 NEUROSCIENCES

影响因子: 最新[2023版] 最新五年平均 出版当年[2022版] 出版当年五年平均 出版前一年[2021版] 出版后一年[2023版]

第一作者:
第一作者机构: [1]Hunan Univ Med, Peoples Hosp Huaihua 1, Gen Hosp, Dept Anesthesiol, 144 South Jinxi Rd, Huaihua 418000, Hunan, Peoples R China
共同第一作者:
通讯作者:
通讯机构: [1]Hunan Univ Med, Peoples Hosp Huaihua 1, Gen Hosp, Dept Anesthesiol, 144 South Jinxi Rd, Huaihua 418000, Hunan, Peoples R China [2]Univ South China, Affiliated Hosp 1, Dept Anesthesiol, Hengyang 421001, Peoples R China [4]Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21287 USA [5]Capital Med Univ, Xuanwu Hosp, Dept Pain Management, 45 Changchun St, Beijing 100053, Peoples R China [6]Cedars Sinai Med Ctr, Board Governors Regenerat Med Inst, Los Angeles, CA 90048 USA
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院